These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19910326)

  • 21. Plasmid-mediated quinolone resistance determinants oqxAB and aac(6')-Ib-cr and extended-spectrum β-lactamase gene blaCTX-M-24 co-located on the same plasmid in one Escherichia coli strain from China.
    Liu BT; Wang XM; Liao XP; Sun J; Zhu HQ; Chen XY; Liu YH
    J Antimicrob Chemother; 2011 Jul; 66(7):1638-9. PubMed ID: 21546384
    [No Abstract]   [Full Text] [Related]  

  • 22. High prevalence of ST131 among CTX-M-producing Escherichia coli from community-acquired infections, in the Czech Republic.
    Papagiannitsis CC; Študentová V; Jakubů V; Španělová P; Urbášková P; Žemličková H; Hrabák J
    Microb Drug Resist; 2015 Feb; 21(1):74-84. PubMed ID: 25188031
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of β-lactamase and 16S rRNA methylase genes among clinical Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from animals.
    Liu BT; Liao XP; Yue L; Chen XY; Li L; Yang SS; Sun J; Zhang S; Liao SD; Liu YH
    Microb Drug Resist; 2013 Jun; 19(3):237-45. PubMed ID: 23289437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relentless increase of resistance to fluoroquinolones and expanded-spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource-limited settings from Latin America.
    Bartoloni A; Pallecchi L; Riccobono E; Mantella A; Magnelli D; Di Maggio T; Villagran AL; Lara Y; Saavedra C; Strohmeyer M; Bartalesi F; Trigoso C; Rossolini GM
    Clin Microbiol Infect; 2013 Apr; 19(4):356-61. PubMed ID: 22414066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey.
    Oktem IM; Gulay Z; Bicmen M; Gur D;
    Jpn J Infect Dis; 2008 Jan; 61(1):13-7. PubMed ID: 18219128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden.
    Östholm Balkhed Å; Tärnberg M; Monstein HJ; Hällgren A; Hanberger H; Nilsson LE
    Scand J Infect Dis; 2013 Apr; 45(4):271-8. PubMed ID: 23113731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization, and comparison, of human clinical and black-headed gull (Larus ridibundus) extended-spectrum beta-lactamase-producing bacterial isolates from Kalmar, on the southeast coast of Sweden.
    Bonnedahl J; Drobni P; Johansson A; Hernandez J; Melhus A; Stedt J; Olsen B; Drobni M
    J Antimicrob Chemother; 2010 Sep; 65(9):1939-44. PubMed ID: 20615928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3.
    Lee SY; Park YJ; Yu JK; Jung S; Kim Y; Jeong SH; Arakawa Y
    J Antimicrob Chemother; 2012 Dec; 67(12):2843-7. PubMed ID: 22893681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escherichia coli isolate coproducing 16S rRNA Methylase and CTX-M-type extended-spectrum beta-lactamase isolated from an outpatient in the United States.
    Doi Y; Adams-Haduch JM; Paterson DL
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1204-5. PubMed ID: 18195064
    [No Abstract]   [Full Text] [Related]  

  • 30. International collaborative study on the occurrence of plasmid-mediated quinolone resistance in Salmonella enterica and Escherichia coli isolated from animals, humans, food and the environment in 13 European countries.
    Veldman K; Cavaco LM; Mevius D; Battisti A; Franco A; Botteldoorn N; Bruneau M; Perrin-Guyomard A; Cerny T; De Frutos Escobar C; Guerra B; Schroeter A; Gutierrez M; Hopkins K; Myllyniemi AL; Sunde M; Wasyl D; Aarestrup FM
    J Antimicrob Chemother; 2011 Jun; 66(6):1278-86. PubMed ID: 21393198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.
    Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H
    Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity in vitro of twelve antibiotics against clinical isolates of extended-spectrum beta-lactamase producing Escherichia coli.
    Sorlózano A; Gutiérrez J; Romero JM; de Dios Luna J; Damas M; Piédrola G
    J Basic Microbiol; 2007 Oct; 47(5):413-6. PubMed ID: 17910106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of extended-spectrum beta-lactamases, antimicrobial resistance genes, and plasmid content in Escherichia coli isolates from different sources in Rio de Janeiro, Brazil.
    Queiroz ML; Antunes P; Mourão J; Merquior VL; Machado E; Peixe LV
    Diagn Microbiol Infect Dis; 2012 Sep; 74(1):91-4. PubMed ID: 22749240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quinolone resistance mechanisms among extended-spectrum beta-lacta- mase (ESBL)-producing Escherichia coli isolated from farm animals in Switzerland.
    Zurfluh K; Cernela N; Stephan R
    Schweiz Arch Tierheilkd; 2015 Jan; 157(1):59-62. PubMed ID: 26753321
    [No Abstract]   [Full Text] [Related]  

  • 35. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTX-M-15, OXA-30 and TEM-1-producing Escherichia coli in two Portuguese regions.
    Mendonça N; Louro D; Castro AP; Diogo J; Caniça M
    J Antimicrob Chemother; 2006 May; 57(5):1014-6. PubMed ID: 16531434
    [No Abstract]   [Full Text] [Related]  

  • 37. CTX-M-3 and CTX-M-15 extended-spectrum beta-lactamases in isolates of Escherichia coli from a hospital in Algiers, Algeria.
    Ramdani-Bouguessa N; Mendonça N; Leitão J; Ferreira E; Tazir M; Caniça M
    J Clin Microbiol; 2006 Dec; 44(12):4584-6. PubMed ID: 16988017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escherichia coli with extended-spectrum β-lactamase and plasmid-mediated quinolone resistance genes in great cormorants and mallards in Central Europe.
    Tausova D; Dolejska M; Cizek A; Hanusova L; Hrusakova J; Svoboda O; Camlik G; Literak I
    J Antimicrob Chemother; 2012 May; 67(5):1103-7. PubMed ID: 22323500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escherichia coli ST131 producing extended-spectrum β-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options.
    Mantengoli E; Luzzaro F; Pecile P; Cecconi D; Cavallo A; Attala L; Bartoloni A; Rossolini GM
    Clin Infect Dis; 2011 Mar; 52(5):690-1. PubMed ID: 21220769
    [No Abstract]   [Full Text] [Related]  

  • 40. Dominance of CTX-M-2 and CTX-M-56 among extended-spectrum beta-lactamases produced by Klebsiella pneumoniae and Escherichia coli isolated in hospitals in Paraguay.
    Khan MA; Lemmens N; Riera E; Blonk T; Goedhart J; Van Belkum A; Goessens W; Hays JP; Van Westreenen M
    J Antimicrob Chemother; 2009 Dec; 64(6):1330-2. PubMed ID: 19854861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.